Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.

Kautzky-Willer A, Kamyar MR, Gerhat D, Handisurya A, Stemer G, Hudson S, Luger A, Lemmens-Gruber R.

Gend Med. 2010 Dec;7(6):571-83. doi: 10.1016/j.genm.2010.12.001.

PMID:
21195357
2.

[Revascularization in patients with type 2 diabetes and coronary artery disease: BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Study Group].

Störk S, Ertl G, Nitschmann S.

Internist (Berl). 2010 May;51(5):674-6. doi: 10.1007/s00108-010-2593-6. German. No abstract available.

PMID:
20352177
3.

[Screening and management of coronary artery disease in diabetic patients].

Kraiem S, Abassi C, Annabi N, Smaali I, Issaa I, Wali M, Malou M, Hannachi S, Longo S, Battikh K, Slimane ML.

Tunis Med. 2006 Oct;84(10):670-6. Review. French.

PMID:
17193866
4.

Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus.

Göbl CS, Brannath W, Bozkurt L, Handisurya A, Anderwald C, Luger A, Krebs M, Kautzky-Willer A, Bischof MG.

Gend Med. 2010 Dec;7(6):593-9. doi: 10.1016/j.genm.2010.11.003.

PMID:
21195359
5.

Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).

Gudbjörnsdottir S, Eeg-Olofsson K, Cederholm J, Zethelius B, Eliasson B, Nilsson PM; Swedish National Diabetes Register (NDR).

Diabet Med. 2009 Jan;26(1):53-60. doi: 10.1111/j.1464-5491.2008.02633.x.

PMID:
19125761
6.

Sex-related psychological effects on metabolic control in type 2 diabetes mellitus.

Kacerovsky-Bielesz G, Lienhardt S, Hagenhofer M, Kacerovsky M, Forster E, Roth R, Roden M.

Diabetologia. 2009 May;52(5):781-8. doi: 10.1007/s00125-009-1318-7. Epub 2009 Mar 10.

PMID:
19277601
7.

Disparity in management of diabetes and coronary heart disease risk factors by sex in DCCT/EDIC.

Larkin ME, Backlund JY, Cleary P, Bayless M, Schaefer B, Canady J, Nathan DM; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.

Diabet Med. 2010 Apr;27(4):451-8. doi: 10.1111/j.1464-5491.2010.02972.x.

PMID:
20536518
8.

Diabetes.

Timmis AD.

Br Med Bull. 2001;59:159-72. Review.

PMID:
11756209
9.

Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes.

Turk HM, Buyukberber S, Sevinc A, Ak G, Ates M, Sari R, Savli H, Cigli A.

Diabetes Care. 2000 Jun;23(6):864-7. No abstract available.

PMID:
10841017
10.

Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.

Chu NV, Kong AP, Kim DD, Armstrong D, Baxi S, Deutsch R, Caulfield M, Mudaliar SR, Reitz R, Henry RR, Reaven PD.

Diabetes Care. 2002 Mar;25(3):542-9. Erratum in: Diabetes Care 2002 May;25(5):947.

PMID:
11874944
11.

Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

Davis TM, Cull CA, Holman RR; U.K. Prospective Diabetes Study (UKPDS) Group.

Diabetes Care. 2001 Jul;24(7):1167-74.

PMID:
11423497
12.

[Preventing infarct in the diabetic patient. Lowering blood glucose and HbA1c are not enough].

Reblin T, Seidel D, Stein D, Görtz A, Lander T.

MMW Fortschr Med. 2003 May 8;145(19):41. German. No abstract available.

PMID:
12813977
13.

[Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation].

Jungmann E, Carlberg C, Schallmayer M, Schumm-Draeger PM.

Med Klin (Munich). 1995 Jul 15;90(7):383-9. German.

PMID:
7675002
14.

[Should the occurrence of a first coronary event change the management of diabetes?].

Timsit J, Dubois-Laforgue D.

Arch Mal Coeur Vaiss. 2000 Dec;93 Spec No 4:39-44. Review. French.

PMID:
11296461
15.

Self-monitoring of blood glucose improved glycemic control and the 10-year coronary heart disease risk profile of female type 2 diabetes patients in Trinidad and Tobago.

Ezenwaka CE, Dimgba A, Okali F, Skinner T, Extavour R, Rodriguez M, Jones-LeCointe A.

Niger J Clin Pract. 2011 Jan-Mar;14(1):1-5. doi: 10.4103/1119-3077.79230.

16.

Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to aNalyse Type 2 diabetes Treatment (GIANTT) observational study.

Voorham J, Haaijer-Ruskamp FM, van der Meer K, de Zeeuw D, Wolffenbuttel BH, Hoogenberg K, Denig P; GIANTT-Group.

Pharmacoepidemiol Drug Saf. 2010 Oct;19(10):1078-86. doi: 10.1002/pds.2023.

PMID:
20687048
17.

Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes.

Venskutonyte L, Malmberg K, Norhammar A, Wedel H, Rydén L.

J Intern Med. 2010 Jul;268(1):75-82. doi: 10.1111/j.1365-2796.2010.02215.x. Epub 2010 Jan 20.

18.

Cardiac complications in non-insulin-dependent diabetes mellitus.

Julien J.

J Diabetes Complications. 1997 Mar-Apr;11(2):123-30. Review.

PMID:
9101398
19.

Glucose control and cardiovascular complications: the VA Diabetes Trial.

Duckworth WC, McCarren M, Abraira C; VA Diabetes Trial.

Diabetes Care. 2001 May;24(5):942-5. No abstract available.

PMID:
11347758
20.

Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483.

PMID:
16861090
Items per page

Supplemental Content

Write to the Help Desk